Anemia or low hemoglobin levels preceding Parkinson disease

Objective: It has been suggested that anemia may be a risk factor for dementia, for restless legs syndrome, and for Parkinson disease (PD). Thus, we investigated the association of anemia with the subsequent risk of PD using a case-control study design. Methods: We used the medical records–linkage system of the Rochester Epidemiology Project to identify 196 subjects who developed PD in Olmsted County, Minnesota, from 1976 through 1995. Each incident case was matched by age (±1 year) and sex to a general population control. We reviewed the complete medical records of cases and controls in the system to detect anemia defined using the World Health Organization criteria. Results: Anemia was more common in the history of cases than of controls (odds ratio 2.00, 95% confidence interval 1.31–3.06, p = 0.001). The association remained significant after adjustment for cigarette smoking, exposure to pesticides, or hysterectomy (in women). The association was not significantly different between men and women, or between PD patients with or without rest tremor. Analyses stratified by time of onset of anemia showed a greater association for anemia that started 20 to 29 years before the onset of PD. Hemoglobin levels were slightly but consistently lower in cases than in controls across all ages. Conclusions: Our results support an association between anemia experienced early in life and the later development of Parkinson disease. The interpretation of this association remains uncertain.

[1]  W. Ondo,et al.  Restless Legs Syndrome , 2010, CNS drugs.

[2]  W. Hening,et al.  RLS and blood donation. , 2009, Sleep medicine.

[3]  N. Zawia,et al.  The Environment, Epigenetics and Amyloidogenesis , 2009, Alzheimer's & Dementia.

[4]  M. Georgieff,et al.  Iron deficiency alters expression of genes implicated in Alzheimer disease pathogenesis , 2008, Brain Research.

[5]  C. Bulpitt,et al.  Haemoglobin, anaemia, dementia and cognitive decline in the elderly, a systematic review , 2008, BMC geriatrics.

[6]  D. Berg,et al.  Genetic variability in the SNCA gene influences α‐synuclein levels in the blood and brain , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  Demao Chen,et al.  Alzheimer's Disease (AD)-Like Pathology in Aged Monkeys after Infantile Exposure to Environmental Metal Lead (Pb): Evidence for a Developmental Origin and Environmental Link for AD , 2008, The Journal of Neuroscience.

[8]  D. Schaid,et al.  Risk of cognitive impairment or dementia in relatives of patients with Parkinson disease. , 2007, Archives of neurology.

[9]  D. Steensma,et al.  Anemia in the elderly: how should we define it, when does it matter, and what can be done? , 2007, Mayo Clinic proceedings.

[10]  N. Kaciroti,et al.  Iron Deficiency in Infancy Predicts Altered Serum Prolactin Response 10 Years Later , 2006, Pediatric Research.

[11]  S. Lydersen,et al.  Prevalence of haemochromatosis gene mutations in Parkinson’s disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[12]  A. Wing,et al.  Blood donations, iron stores, and risk of Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[13]  E. Beutler,et al.  The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? , 2006, Blood.

[14]  B. Winblad,et al.  Anaemia increases the risk of dementia in cognitively intact elderly , 2006, Neurobiology of Aging.

[15]  Matteo Cesari,et al.  Predictors of Combined Cognitive and Physical Decline , 2005, Journal of the American Geriatrics Society.

[16]  M. Mattson,et al.  Role of dietary iron restriction in a mouse model of Parkinson's disease , 2004, Experimental Neurology.

[17]  Luigi Ferrucci,et al.  Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. , 2004, Blood.

[18]  Hiroko H Dodge,et al.  Hemoglobin levels and Alzheimer disease: an epidemiologic study in India. , 2004, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[19]  J. Beard,et al.  Neonatal iron deficiency results in irreversible changes in dopamine function in rats. , 2003, The Journal of nutrition.

[20]  M. Mattson,et al.  Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders , 2003, Trends in Neurosciences.

[21]  E. Beutler,et al.  Seeking candidate mutations that affect iron homeostasis. , 2002, Blood cells, molecules & diseases.

[22]  D. Maraganore,et al.  Nonfatal Cancer Preceding Parkinson’s Disease: A Case-Control Study , 2002, Epidemiology.

[23]  D. Schaid,et al.  Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: An exploratory case‐control study , 2001, Movement disorders : official journal of the Movement Disorder Society.

[24]  C. Tanner,et al.  Frequency of bowel movements and the future risk of Parkinson’s disease , 2001, Neurology.

[25]  S. Landahl,et al.  Blood haemoglobin declines in the elderly: implications for reference intervals fromage 70 to 88 , 2000, European journal of haematology.

[26]  D. Schaid,et al.  Anxiety disorders and depressive disorders preceding Parkinson's disease: A case‐control study , 2000, Movement disorders : official journal of the Movement Disorder Society.

[27]  D. Maraganore,et al.  Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990 , 1999, Neurology.

[28]  J W Langston,et al.  Parkinson disease in twins: an etiologic study. , 1999, JAMA.

[29]  T. Spector,et al.  Genes control the cessation of a woman's reproductive life: a twin study of hysterectomy and age at menopause. , 1998, The Journal of clinical endocrinology and metabolism.

[30]  J S Rakshi,et al.  Measuring the rate of progression and estimating the preclinical period of Parkinson’s disease with [18F]dopa PET , 1998, Journal of neurology, neurosurgery, and psychiatry.

[31]  P. Hillas,et al.  Characterization of the Active Site Iron in Tyrosine Hydroxylase , 1996, The Journal of Biological Chemistry.

[32]  L. Melton,et al.  History of the Rochester Epidemiology Project. , 1996, Mayo Clinic proceedings.

[33]  Mark W. Mahowald,et al.  Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder , 1996, Neurology.

[34]  Robert Hill,et al.  Low platelet mitochondrial complex I and complex II/III activity in early untreated parkinson's disease , 1995, Annals of neurology.

[35]  J. Parks,et al.  Abnormalities of the electron transport chain in idiopathic parkinson's disease , 1989, Annals of neurology.

[36]  W. Gibb,et al.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[37]  J. Connor,et al.  Analysis of ferritin genes in Parkinson disease. , 2007, Clinical chemistry and laboratory medicine.

[38]  R. Stoltzfus,et al.  Guidelines for the use of iron supplements to prevent and treat iron deficiency anemia , 1998 .

[39]  H. Yoshino,et al.  Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease , 1992, Journal of neural transmission. Parkinson's disease and dementia section.

[40]  Nutritional anaemias. Report of a WHO scientific group. , 1968, World Health Organization technical report series.